107 Results for: created: (01/2018 to 01/2018)

People

  1. Adusumilli
    Adusumilli
  2. Eguchi
    Eguchi
  3. Jones
    Jones
  4. Travis
    Travis
  5. Lu
    Lu
  6. Rimner
    Rimner
  7. Zelefsky
    Zelefsky
  8. Zhang
    Zhang
  9. Downey
    Downey
  10. Kollmeier
    Kollmeier

Groups

  1. Department of Medicine (40)
  2. Surgery (39)
  3. Sloan Kettering Institute Postdocs (34)
  4. Solid Tumor Oncology Division (33)
  5. Epidemiology and Biostatistics (23)
  6. Radiation Oncology, Department of (22)
  7. Survivorship Research (21)
  8. Biostatistics Service (20)
  9. Department of Pathology and Laboratory Medicine (20)
  10. Thoracic Oncology (19)
  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (65)
  2. Journal Article (41)
  3. Book Section (1)
Groups
  1. Department of Medicine (40)
  2. Surgery (39)
  3. Sloan Kettering Institute Postdocs (34)
  4. Solid Tumor Oncology Division (33)
  5. Epidemiology and Biostatistics (23)
  6. Radiation Oncology, Department of (22)

More Groups

People
  1. Prasad Adusumilli (25)
  2. Takashi Eguchi (19)
  3. David Jones (17)
  4. William Travis (15)
  5. Shaohua Lu (11)
  6. Kay See Tan (9)

More People

Years
  1. 2018 (14)
  2. 2017 (79)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (5)
  6. 2009 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (53)
  2. International Journal of Radiation Oncology, Biology, Physics (9)
  3. European Journal of Cancer (5)
  4. Radiotherapy and Oncology (5)
  5. Seminars in Radiation Oncology (4)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. Elsevier Inc. (107)

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A stem-cell oriented phylogeny of non-small cell lung cancers
    Meeting Abstract

    Downey, R.; Riester, M.; Wu, H. J.; Moreira, A.; Michor, F.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy
    Meeting Abstract

    Paik, P.; Stammberger, U.; Bruns, R.; Overton, L.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
    Meeting Abstract

    Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • The use of immunohistochemistry improves the diagnosis of SCLC. An international reproducibility study in a demanding set of cases
    Meeting Abstract

    Thunnissen, E.; Borczuk, A.; Flieder, D.; Witte, B.; Beasley, M. B.; Chung, J. H.; Dacic, S.; Lantuejoul, S.; Russell, P.; Den Bakker, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A multi-national cohort validation of procedure-specific nomograms to predict recurrence for small lung adenocarcinomas
    Meeting Abstract

    Bains, S.; Eguchi, T.; Warth, A.; Yeh, Y. C.; Nitadori, J. I.; Woo, K.; Chou, T. Y.; Dienemann, H.; Muley, T.; Nakajima, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Safety, clinical activity and biomarker results from a phase lb study of erlotinib plus atezolizumab in advanced NSCLC
    Meeting Abstract

    Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1 study of ramucirumab or necitumumab in combination with osimertinib (AZD9291) in advanced T790M-positive EGFR-mutant NSCLC
    Meeting Abstract

    Planchard, D.; Kris, M.; Besse, B.; Hozak, R.; He, S.; Gan, F.; Wolff, K.; Chao, B.; Yu, H.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Reproducibility of comprehensive histologic assessment and refining histologic criteria in P staging of multiple tumor nodules
    Meeting Abstract

    Nicholson, A.; Viola, P.; Torkko, K.; Duhig, E.; Geisinger, K.; Borczuk, A.; Hiroshima, K.; Tsao, M.; Warth, A.; Lantuejoul, S.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • SBRT and sequential chemotherapy for stage IIA to IIIA non-small cell lung cancer - A phase I dose escalation study
    Meeting Abstract

    Von Reibnitz, D.; Chaft, J.; Wu, A.; Gelblum, D.; Yorke, E.; Gelb, E.; Mitchell, S.; Ng, K.; Rimner, A.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save